No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CLRB Cellectar BioSciences
- 3.4200
- +0.0800+2.40%
Close May 3 16:00 ET
- 3.4599
- +0.0399+1.17%
Post 17:24 ET
122.60MMarket Cap-1099P/E (TTM)
3.5100High3.3400Low510.74KVolume3.3400Open3.3400Pre Close1.75MTurnover1.90%Turnover RatioLossP/E (Static)35.85MShares4.450052wk High-16.52P/B92.02MFloat Cap1.330052wk Low--Dividend TTM26.91MShs Float13678193.1609Historical High--Div YieldTTM5.09%Amplitude1.2500Historical Low3.4280Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal
Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?
Buy Rating on Cellectar Biosciences Backed by Promising Drug Candidate and Solid Financials
Cellectar Biosciences Price Target Raised to $28.00/Share From $20.00 by Roth MKM
Cellectar Biosciences Price Target Raised to $28.00/Share From $20.00 by Roth MKM
Cellectar Biosciences Is Maintained at Buy by Roth MKM
Cellectar Biosciences Is Maintained at Buy by Roth MKM
Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS)
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg